Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2016 Volume 11 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2016 Volume 11 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Sclerostin is essential for alveolar bone loss in occlusal hypofunction

  • Authors:
    • Yang Xu
    • Lufei Wang
    • Yao Sun
    • Xianglong Han
    • Tian Gao
    • Xin Xu
    • Tian Chen
    • Xuefeng Zhao
    • Huan Zeng
    • Yanmin Wang
    • Ding Bai
  • View Affiliations / Copyright

    Affiliations: Department of Orthodontics, State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Oral Implantology, Dental Transformation Medical Center, College of Stomatology, Tongji University, Shanghai 200011, P.R. China, Department of Obstetrics and Gynecology, Transformation Medical Center, Tongji University, Shanghai 200011, P.R. China
  • Pages: 1812-1818
    |
    Published online on: March 2, 2016
       https://doi.org/10.3892/etm.2016.3124
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Bone loss is caused by occlusal hypofunction and is a serious health concern. This is particularly true of tooth loss, which is common in the elderly. However, the cellular and molecular mechanisms underlying bone loss have yet to be fully elucidated. Sclerostin and Wnt/β‑catenin signaling have previously been reported to serve important roles in regulating bone remodeling. Therefore, the present study aimed to investigate the involvement of sclerostin and Wnt/β‑catenin signaling in occlusal hypofunction‑induced alveolar bone remodeling. The unilateral maxillary molars of 14 male Sprague‑Dawley rats were extracted in order to establish a model of occlusal hypofunction. For each rat, the non‑extraction side was treated as the control group for comparisons with the extraction side. At 8 weeks after tooth extraction, the rats were sacrificed and alveolar bone specimens were harvested for X‑ray radiography, micro‑computed tomography (CT) and histological and immunohistochemical examinations. Bone loss and architecture deterioration were observed at the occlusal hypofunction side. The bone mineral density was markedly decreased and the ratio of bone volume to total volume was significantly decreased at the hypofunction side, as compared with the control side (P<0.001). In addition, the number of osteoclasts at the hypofunction side were significantly increased compared with that in the control side (P<0.001), as demonstrated using tartrate‑resistant acid phosphatase staining. Furthermore, the protein expression levels of sclerostin and receptor activator of nuclear factor‑κB ligand were increased, whereas those of β‑catenin were decreased, at the hypofunction side when compared with the control side. In conclusion, the results of the present study suggested that occlusal hypofunction‑induced bone loss may be associated with upregulated expression of sclerostin, which, in turn, may inhibit the activity of the Wnt/β‑catenin signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Recent advances in oral health. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 826:1–37. 1992.PubMed/NCBI

2 

Müller F, Naharro M and Carlsson GE: What are the prevalence and incidence of tooth loss in the adult and elderly population in Europe? Clin Oral Implants Res. 18(Suppl 3): S2–S14. 2007. View Article : Google Scholar

3 

Harada S and Rodan G: Control of osteoblast function and regulation of bone mass. Nature. 423:349–355. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Jacobs CR, Temiyasathit S and Castillo AB: Osteocyte mechanobiology and pericellular mechanics. Annu Rev Biomed Eng. 12:369–400. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Bikle DD and Halloran BP: The response of bone to unloading. J Bone Miner Metab. 17:233–244. 1999. View Article : Google Scholar : PubMed/NCBI

6 

Shimomoto Y, Chung CJ, Iwasaki HY, Muramoto T and Soma K: Effects of occlusal stimuli on alveolar/jaw bone formation. J Dent Res. 86:47–51. 2007. View Article : Google Scholar : PubMed/NCBI

7 

von Wowern N, Hjørting-Hansen E and Stoltze K: Changes in bone mass in rat mandibles after tooth extraction. Int J Oral Surg. 8:229–233. 1979. View Article : Google Scholar : PubMed/NCBI

8 

Ejiri S, Toyooka E, Tanaka M, Anwar RB and Kohno S: Histological and histomorphometrical changes in rat alveolar bone following antagonistic tooth extraction and/or ovariectomy. Arch Oral Biol. 51:941–950. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Kuroda S, Mukohyama H, Kondo H, Aoki K, Ohya K, Ohyama T and Kasugai S: Bone mineral density of the mandible in ovariectomized rats: Analyses using dual energy X-ray absorptiometry and peripheral quantitative computed tomography. Oral Dis. 9:24–28. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Elovic RP, Hipp JA and Hayes WC: Maxillary molar extraction decreases stiffness of the mandible in ovariectomized rats. J Dent Res. 73:1735–1741. 1994.PubMed/NCBI

11 

Elovic RP, Hipp JA and Hayes WC: Maxillary molar extraction causes increased bone loss in the mandible of ovariectomized rats. J Bone Miner Res. 10:1087–1093. 1995. View Article : Google Scholar : PubMed/NCBI

12 

Glass DA II and Karsenty G: Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr Top Dev Biol. 73:43–84. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, Ito M, Takeshita S and Ikeda K: Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5:464–475. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Weidauer SE, Schmieder P, Beerbaum M, Schmitz W, Oschkinat H and Mueller TD: NMR structure of the Wnt modulator protein sclerostin. Biochem Biophys Res Commun. 380:160–165. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW and Reeve J: Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 19:1842–1844. 2005.PubMed/NCBI

16 

Bonewald LF and Johnson M: Osteocytes, mechanosensing and Wnt signaling. Bone. 42:606–615. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Galli C, Passeri G and Macaluso GM: Osteocytes and WNT: The mechanical control of bone formation. J Dent Res. 89:331–343. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Paszty C, Turner CH and Robinson MK: Sclerostin: A gem from the genome leads to bone-building antibodies. J Bone Miner Res. 25:1897–1904. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Wijenayaka AR, Kogawa M, Lim HP, Bonewald LF, Findlay DM and Atkins GJ: Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One. 6:e259002011. View Article : Google Scholar : PubMed/NCBI

20 

Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Li Y, Feng G, Gao X and He L: Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res. 24:1651–1661. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Naveh GR, Lev-Tov CN, Zaslansky P, Shahar R and Weiner S: Tooth-PDL-bone complex: Response to compressive loads encountered during mastication-a review. Arch Oral Biol. 57:1575–1584. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Gerritsen AE, Allen PF, Witter DJ, Bronkhorst EM and Creugers NH: Tooth loss and oral health-related quality of life: A systematic review and meta-analysis. Health Qual Life Outcomes. 8:1262010. View Article : Google Scholar : PubMed/NCBI

23 

Schropp L, Wenzel A, Kostopoulos L and Karring T: Bone healing and soft tissue contour changes following single-tooth extraction: A clinical and radiographic 12-month prospective study. Int J Periodontics Restorative Dent. 23:313–323. 2003.PubMed/NCBI

24 

Tan WL, Wong TL, Wong MC and Lang NP: A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin Oral Implants Res. 23(Suppl 5): S1–S21. 2012. View Article : Google Scholar

25 

Sennerby L, Carsson GE, Bergman B and Warfvinge J: Mandibular bone resorption in patients treated with tissue-integrated prostheses and in complete-denture wearers. Acta Odontol Scand. 46:135–140. 1988. View Article : Google Scholar : PubMed/NCBI

26 

Bodic F, Hamel L, Lerouxel E, Baslé MF and Chappard D: Bone loss and teeth. Joint Bone Spine. 72:215–221. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Klein-Nulend J, Bakker AD, Bacabac RG, Vatsa A and Weinbaum S: Mechanosensation and transduction in osteocytes. Bone. 54:182–190. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Bonewald LF: The amazing osteocyte. J Bone Miner Res. 26:229–238. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Bonewald LF: Mechanosensation and transduction in osteocytes. Bonekey Osteovision. 3:7–15. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE and Turner CH: Mechanical stimulation of bone in vivo reduces osteocyte expression of sost/sclerostin. J Biol Chem. 283:5866–5875. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S and Krumlauf R: Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res. 21:1738–1749. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Tu X, Rhee Y, Condon KW, Bivi N, Allen MR, Dwyer D, Stolina M, Turner CH, Robling AG, Plotkin LI and Bellido T: Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone. 50:209–217. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Lewiecki EM: Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases. Ther Adv Musculoskelet Dis. 6:48–57. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Virdi AS, Irish J, Sena K, Liu M, Ke HZ, McNulty MA and Sumner DR: Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis. J Bone Joint Surg Am. 97:133–40. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Moe SM, Chen NX, Newman CL, Organ JM, Kneissel M, Kramer I, Gattone VH 2nd and Allen MR: Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res. 30:499–509. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Costa AG, Bilezikian JP and Lewiecki EM: The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorder. Curr Opin Nephrol Hypertens. 24:324–329. 2015.PubMed/NCBI

37 

Tanaka Y, Nakayamada S and Okada Y: Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy. 4:325–328. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, et al: Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 17:1231–1234. 2011. View Article : Google Scholar : PubMed/NCBI

39 

Semënov M, Tamai K and He X: SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 280:26770–26775. 2005. View Article : Google Scholar : PubMed/NCBI

40 

Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE and Wu D: Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem. 280:19883–19887. 2005. View Article : Google Scholar : PubMed/NCBI

41 

Muramoto T, Takano Y and Soma K: Time-related changes in periodontal mechanoreceptors in rat molars after the loss of occlusal stimuli. Arch Histol Cytol. 63:369–380. 2000. View Article : Google Scholar : PubMed/NCBI

42 

Lekic P and McCulloch CA: Periodontal ligament cell population: The central role of fibroblasts in creating a unique tissue. Anat Rec. 245:327–341. 1996. View Article : Google Scholar : PubMed/NCBI

43 

Ke HZ, Richards WG, Li X and Ominsky MS: Sclerostin and dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev. 33:747–783. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Shahnazari M, Wronski T, Chu V, Williams A, Leeper A, Stolina M, Ke HZ and Halloran B: Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody. Calcif Tissue Int. 91:50–58. 2012. View Article : Google Scholar : PubMed/NCBI

45 

Spatz JM, Ellman R, Cloutier AM, Louis L, van Vliet M, Suva LJ, Dwyer D, Stolina M, Ke HZ and Bouxsein ML: Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res. 28:865–874. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu Y, Wang L, Sun Y, Han X, Gao T, Xu X, Chen T, Zhao X, Zeng H, Wang Y, Wang Y, et al: Sclerostin is essential for alveolar bone loss in occlusal hypofunction. Exp Ther Med 11: 1812-1818, 2016.
APA
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X. ... Bai, D. (2016). Sclerostin is essential for alveolar bone loss in occlusal hypofunction. Experimental and Therapeutic Medicine, 11, 1812-1818. https://doi.org/10.3892/etm.2016.3124
MLA
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X., Chen, T., Zhao, X., Zeng, H., Wang, Y., Bai, D."Sclerostin is essential for alveolar bone loss in occlusal hypofunction". Experimental and Therapeutic Medicine 11.5 (2016): 1812-1818.
Chicago
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X., Chen, T., Zhao, X., Zeng, H., Wang, Y., Bai, D."Sclerostin is essential for alveolar bone loss in occlusal hypofunction". Experimental and Therapeutic Medicine 11, no. 5 (2016): 1812-1818. https://doi.org/10.3892/etm.2016.3124
Copy and paste a formatted citation
x
Spandidos Publications style
Xu Y, Wang L, Sun Y, Han X, Gao T, Xu X, Chen T, Zhao X, Zeng H, Wang Y, Wang Y, et al: Sclerostin is essential for alveolar bone loss in occlusal hypofunction. Exp Ther Med 11: 1812-1818, 2016.
APA
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X. ... Bai, D. (2016). Sclerostin is essential for alveolar bone loss in occlusal hypofunction. Experimental and Therapeutic Medicine, 11, 1812-1818. https://doi.org/10.3892/etm.2016.3124
MLA
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X., Chen, T., Zhao, X., Zeng, H., Wang, Y., Bai, D."Sclerostin is essential for alveolar bone loss in occlusal hypofunction". Experimental and Therapeutic Medicine 11.5 (2016): 1812-1818.
Chicago
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X., Chen, T., Zhao, X., Zeng, H., Wang, Y., Bai, D."Sclerostin is essential for alveolar bone loss in occlusal hypofunction". Experimental and Therapeutic Medicine 11, no. 5 (2016): 1812-1818. https://doi.org/10.3892/etm.2016.3124
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team